ClinicalTrials.gg
Sign In

Diabetic Nephropathies clinical trials

The registry lists 543 studies for Diabetic Nephropathies across more than 10 countries. 110 are recruiting or about to start. 383 of them are mainly about Diabetic Nephropathies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 761 studies for Diabetic Nephropathies. How that becomes 543 here

This page counts the studies the registry files under Diabetic Nephropathies, and those it files under no condition that list Diabetic Nephropathiesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 761Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −13List Diabetic Nephropathies as a condition, but the registry did not file them under itMost often written as “Diabetic Nephropathy Type 2” (6), “Macroalbuminuric Diabetic Nephropathy” (1), and “Type 2 Diabetes Mellitus With Established Diabetic Nephropathy” (1). The registry filed them under other conditions only, most often Diabetes Mellitus, Type 2 (6) and Renal Insufficiency, Chronic (4).
  3. −205Match it another way52 name it in the title, 2 in a keyword, and 151 by a synonym or other text the search reads.
  4. 543The count on this page26 of them list Diabetic Nephropathies in their own words; the registry filed them under no condition.

Get an email when these change. Save the Diabetic Nephropathies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
292
Status unknown
71
Not yet recruiting
55
Recruiting
50
Terminated
32
Active, not recruiting
23

Phase

Phase 2
144
Phase 4
69
Phase 3
59
Phase 1
41
Early Phase 1
5

Where

United States
153
China
75
Denmark
41
Canada
34
Japan
30
Australia
27

Who runs them

Assiut University (25) · University of Colorado, Denver (11) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (10) · Steno Diabetes Center Copenhagen (9) · Tanta University (8) · Bayer (8) · Mitsubishi Tanabe Pharma Corporation (6) · Boehringer Ingelheim (6)

What is being tested here

Drugs under test in Diabetic Nephropathies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Finerenone439
Empagliflozin2410
Dapagliflozin216
Sotagliflozin212
Lisinopril116
Telmisartan115
Enalapril103
Diosuxentan102
Isuzinaxib102
Semaglutide112

Drug classes tested here SGLT2 inhibitors 6 open · Mineralocorticoid receptor antagonists (MRAs) 4 open · Angiotensin receptor blockers (ARBs) 1 open · ACE inhibitors 1 open · Endothelin receptor antagonists 1 open

Coming up

7phase 3 studies under way
43studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 50 Diabetic Nephropathies studies recruiting now, 23 (46%) set no upper age limit and 16 (32%) stop at 75 or younger. 5 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 8 (16%) take healthy volunteers.

Recruiting studies that take each age, of 50
AgeWomenMen
103 (6%)3 (6%)
1838 (76%)38 (76%)
3045 (90%)45 (90%)
4046 (92%)46 (92%)
5046 (92%)46 (92%)
6547 (94%)47 (94%)
7542 (84%)42 (84%)
8526 (52%)26 (52%)

Across all 543 studies, recruiting or not: 43% stop at 75 or younger and 15% at 65; 6% take children; <1% are for women only and 1% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Diabetic Nephropathies studies take

Of 52 phase 2 interventional studies under Diabetic Nephropathies, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 119 mo11–37 · 20 studies——
Phase 221 mo13–31 · 52 studies20 mo14–28 · 32 studies—
Phase 354 mo25–65 · 16 studies——
Phase 433 mo21–42 · 21 studies——
Interventional, no phase23 mo11–37 · 50 studies—23 mo10–37 · 49 studies
Observational67 mo25–… · 38 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 543. Browse all 543 → or search them.